Track the 동구바이오제약 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 동구바이오제약 has logged 58 reports. Market capitalisation: €104.9bn. The latest transaction was filed on 15 July 2026 (Sale). Among the most active insiders: 조용준. Every trade is accessible without an account.
56
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
17 ops.
Sell Volume
3Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 4,292 of 29,057 companies
70.2
score / 100
Value
68
Quality
72
FCF yld-25%
Earn yld51%
EV/EBITDA3.1x
ROE·
Gross mgn60%
Net mgn21%
Debt/EBITDA1.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Donggu Bio Pharmaceutical es una empresa de salud y farmacéutica que cotiza en el mercado XKRX. Se especializa en el desarrollo y la fabricación de productos farmacéuticos.